Document Detail


A ten-year remission maintained by 6,272 mg (3,920 mg/m2) cumulative dose of cisplatin-based chemotherapy for recurrent epithelial ovarian cancer.
MedLine Citation:
PMID:  11874068     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Since cisplatin is a heavy metal, renal and neurotoxicity is considered to be dose limiting in solid tumors. The current case is unusual in that remission has been maintained in a patient with recurrent epithelial ovarian cancer by cisplatin-based chemotherapy without evidence of renal or neurotoxicity, while receiving a total dose of 6,270 mg (3,920 mg/m2) of cisplatin over 11 1/2 years.
Authors:
M S Piver
Related Documents :
21541568 - Impact of tumor cell kinetics on the outcome of induction chemotherapy in oral carcinom...
1702148 - A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplat...
21555688 - Treatment of patients with metastatic urothelial cancer "unfit" for cisplatin-based che...
8388318 - Preclinical antitumor evaluation of bis-acetato-ammine-dichloro-cyclohexylamine platinu...
19860618 - Monitoring of plasma cell proliferative and apoptotic indices in the course of multiple...
14742758 - Severe dermatologic reactions at multiple sites after paclitaxel administration.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  European journal of gynaecological oncology     Volume:  22     ISSN:  0392-2936     ISO Abbreviation:  Eur. J. Gynaecol. Oncol.     Publication Date:  2001  
Date Detail:
Created Date:  2002-03-04     Completed Date:  2002-08-15     Revised Date:  2006-04-24    
Medline Journal Info:
Nlm Unique ID:  8100357     Medline TA:  Eur J Gynaecol Oncol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  403-5     Citation Subset:  IM    
Affiliation:
Sisters of Charity Hospital, Buffalo, NY 14214, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Cisplatin / administration & dosage*,  adverse effects
Female
Humans
Kidney / drug effects
Neoplasm Recurrence, Local / drug therapy*
Neoplasms, Glandular and Epithelial / drug therapy*
Ovarian Neoplasms / drug therapy*
Chemical
Reg. No./Substance:
15663-27-1/Cisplatin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Vulval intraepithelial neoplasia: current perspectives.
Next Document:  Treatment of metastatic invasive moles in two husband-side sisters-in-law. Case reports and review o...